BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8016474)

  • 1. Immunosuppressive drugs and their effects.
    Superdock KR; Helderman JH
    Semin Respir Infect; 1993 Sep; 8(3):152-9. PubMed ID: 8016474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant immunopharmacology: you can fool with mother nature!
    Vasquez EM; Westin ED
    Nurs Case Manag; 1999; 4(1):37-48. PubMed ID: 10232222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation.
    Dandel M; Lehmkuhl HB; Knosalla C; Hetzer R
    Transpl Immunol; 2010 Jul; 23(3):93-103. PubMed ID: 20434559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New immunosuppressive therapies in kidney transplantation].
    Pomer S
    Urologe A; 1994 Sep; 33(5):370-6. PubMed ID: 7974924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive agents in organ transplantation].
    Bergan S; Albrechtsen D; Bentdal O
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3615-20. PubMed ID: 10563181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of immunosuppressive therapy in organ transplantation.
    MacGregor MS; Bradley JA
    Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):276-84. PubMed ID: 8542176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the use of cyclosporine in renal transplantation.
    Yoshimura N; Okamoto M; Akioka K; Kaihara S
    Transplant Proc; 2004 Mar; 36(2 Suppl):181S-185S. PubMed ID: 15041333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment: surveillance, toxicity, prospects].
    Giral M; Dantal J; Soulillou JP
    Rev Prat; 1994 Feb; 44(4):442-8. PubMed ID: 8184259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cyclosporine on the development of immunosuppressive therapy.
    Haberal M; Emiroglu R; DalgiƧ A; Karakayli H; Moray G; Bilgin N
    Transplant Proc; 2004 Mar; 36(2 Suppl):143S-147S. PubMed ID: 15041325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft immunity in lung transplantation].
    Mornex JF
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells.
    Lim DG; Joe IY; Park YH; Chang SH; Wee YM; Han DJ; Kim SC
    Transpl Immunol; 2007 Nov; 18(2):94-100. PubMed ID: 18005851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.